The research compound in Alli^®

Alli^® is a weight management (over the counter) medicine from GlaxoSmithKline. Its active compound is Orlistat — which is what this catalogue supplies, as a research material.

This is not Alli^®, and NOVALYTE LABS has no affiliation with GlaxoSmithKline. We supply the compound Orlistat for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Alli^® is a trademark of GlaxoSmithKline, referenced here only to identify the compound.

Alli is the lower-dose, over-the-counter presentation of orlistat, the same compound sold on prescription as Xenical.

Orlistat inhibits pancreatic lipase in the gut, acting locally on fat absorption rather than systemically on appetite.

The compound is listed here as a research material with batch documentation.

Orlistat in this catalogue

Other brands using Orlistat

The same compound is marketed under more than one brand, usually because each brand carries a different approved indication.